anti-epileptic drug
Scope
Date
~
-
Bio & Pharma
SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...
Jul 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
1 in 4 biotech firms struggles with decreasing cash reserves
South Korea’s biotechnology firms – public and private alike – are facing increasingly negative financial conditions. T...
Jun 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 anti-tank missile in spotlight amid Ukraine war
An anti-tank guided weapon produced by South Korean defense exporter LIG Nex1 Co. is in the spotlight as Ukraine said its forces destroyed Russian a...
Apr 15, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
-
Corporate strategy
SK Chemicals to invest $1.6 bn in green, biopharmaceutical sectors
South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...
Mar 28, 2022 (Gmt+09:00)
language -
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Upcoming IPOs
Korea’s Voronoi in talks with global firms on drug designs
South Korea’s biotechnology startup Voronoi Inc. is in talks with global biomedical companies on drug designs as it aims to expand the busines...
Mar 04, 2022 (Gmt+09:00)
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
-
Pharmaceuticals
HK inno.N’s K-CAB a blockbuster drug with $843 million exports
South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...
Dec 24, 2021 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
Biosimilars
Samsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
-
Tech, Media & Telecom
S.Korea fines Google $180 mn for operating system market abuse
South Korea's Fair Trade Commission (FTC) on Tuesday imposed a fine of 207.4 billion won ($180 million) on Google, alongside a correction order, aft...
Sep 14, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Biotech
LegoChem’s biotech platform drives 28% share price spike over last month
The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...
Jul 07, 2021 (Gmt+09:00)
language -
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
COVID-19
Eyegene to kick off Korea’s first mRNA clinical trial
Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...
Jul 01, 2021 (Gmt+09:00)
-
IPOs
HK inno.N poised to bolster S.Korea's IPO lineup in H2
HK inno.N Corp., a pharmaceuticals unit of South Korea's Kolmar Korea, is set to go public in early August at a valuation of around 2 trillion won (...
Jun 29, 2021 (Gmt+09:00)
-
Automobiles
US anti-dumping duties add to Korean tire makers' woes
The US trade body’s approval of anti-dumping tariffs on tire imports from South Korea, Taiwan and Thailand is adding to the woes of Korea&rsqu...
Jun 24, 2021 (Gmt+09:00)
language -
Automobiles
Tennessee mayors oppose ITC’s anti-dumping duties on Hankook Tire
Politicians in the US state of Tennessee are urging the International Trade Commission (ITC) to avoid hurting the operations of Hankook Tire & T...
Jun 14, 2021 (Gmt+09:00)
-
Medicine
Celltrion, Mirae to take largest stake in UK biotech firm
South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...
Jun 07, 2021 (Gmt+09:00)
language -
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language -
Drug development
SK injects $200 mn into Roivant partnership for new drug development
SK Holdings Co., the holding company of South Korean conglomerate SK Group, has become the first Korean company to foray into the targeted protein d...
Dec 07, 2020 (Gmt+09:00)
-
Tech, Media & Telecom
LS Cable develops anti-hacking optical cables
LS Cable & System Ltd., South Korea's leading wire and cable manufacturer, has developed a new optical cable that can help ward against data breac...
Nov 03, 2020 (Gmt+09:00)